Thursday, 17th October Australian and New Zealand Obesity Society Annual Scientific Conference 2024

Stephen Simpson
Roseline Ribeiro
Maria Fiatarone Singh
Peter Ebeling

• It takes a village – evaluating a neighbourhood approach to improve health and wellbeing - Kristy A Bolton
• Group education leads to positive healthy habits changes - Kerryn Chisholm
• Prevalence of high BMI during the first 3 years of life: using New Zealand national electronic health data - Lisa Daniels
• Effects of nutrition and other health-oriented marketing claims on young adults’ perceptions and hypothetical consumption of alcohol products: an online experiment  - Helen Dixon
• Why do findings between rigorous randomised trials and meta-analyses evaluating pregnancy interventions to limit gestational weight gain differ? - Jodie M Dodd
• Impulsivity its relationship to other lifestyle habits and weight loss at a tertiary weight loss clinic - Janet Franklin
• Weight loss and remission of pre-diabetes with an evidence-based lifestyle intervention - Mandy Ho
• Access to allied health and specialist obesity services are barriers to obesity care in rural and regional populations in Australia. - Samantha Hocking
• Barriers and facilitators of preparing home-made meals among Australian adults who made financially-driven food changes in the past year - Elizaveta Ilchenko
• Can you hear the change? Finding new ways to communicate nutrition information to parents. - Nicole James
• A mapping review of Australian and international obesity-related policies for women during preconception, pregnancy, and postpartum periods using a weight stigma lens. - Helia Khalesi
• Using online photovoice to understand larger bodied women’s experience in Australian maternity care: A pilot study - Helia Khalesi
• The evidence behind all the hype: A retrospective study of the efficacy of semaglutide 1 mg for the treatment of obesity in adults with prediabetes or normoglycaemia - Akash Konantambigi
• Patient experiences with tirzepatide in SURMOUNT-4 - Roger Chen
• Efficacy of tirzepatide in achieving the composite endpoints of glycemic, blood pressure and lipid goals in SURMOUNT-2 - Melissa Leung
• Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes - Melissa Leung
• Unpacking adolescent weight management interventions: a synthesis of delivery features and behaviour change strategies - Natalie Lister
• Does exercise preserve fat free mass during a very low energy diet in patients with obstructive sleep apnea and overweight or obesity? - Elizabeth A Machan
• Antecedents of weight stigma in Australian undergraduate students - Megan Mitchell
• Glucagon and GLP-1 receptor dual agonist survodutide improved liver histology in people with MASH and fibrosis: Results from a randomized, double-blind, placebo-controlled phase 2 trial - Morag Nelson
• Chrono-Nutrition for Weight Management: A Systematic Review and Meta-Analysis - Hayley M O'Neill
• Temporal changes in quality of the food environment at a weekly market in Tasmania - Helen M Parker
• Aboriginal community perspectives on adapting a healthy lifestyle program - Stephen Paull
• Australians with Obesity: disease burden, management, and resource impact - Gaurav Puri
• What is the effect of non-ketogenic, diet-induced weight loss on appetite markers in adults with overweight and obesity? A systematic review and meta-analysis - Jessica Roekenes
• Prevalence and trends in Australian secondary school students’ diet and activity behaviours - Maree Scully
• Once-weekly semaglutide in heart failure with preserved ejection fraction and obesity: main results from the STEP-HFpEF trial - Andrew Sindone
• Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial - Andrew Sindone
• The role of overweight and obesity in explaining perinatal outcome differences between women with type 1 and type 2 diabetes - Praveena Raviraj
• Obesity management in primary care in Australia – a general practitioner survey. - Terri-Lynne South
• The role of bioelectrical impedance analysis in predicting 12-month weight loss in people with class 3 obesity - Mina Toumas
•   Review of Neuro-Development disorder referrals and their journey through Whānau Pakari from 2021- 2024   - Lisa L Wynter

Dinner, Drinks & Entertainment Included.
Complimentary buses will depart from the Novotel starting at 6:45pm. Return buses to the Novotel will be available at 10pm and at conclusion of the evening at 11pm.